M
Maria Teresa Tome Esteban
Researcher at St George’s University Hospitals NHS Foundation Trust
Publications - 25
Citations - 1116
Maria Teresa Tome Esteban is an academic researcher from St George’s University Hospitals NHS Foundation Trust. The author has contributed to research in topics: Hypertrophic cardiomyopathy & Cardiomyopathy. The author has an hindex of 12, co-authored 18 publications receiving 993 citations. Previous affiliations of Maria Teresa Tome Esteban include University College London & University College Hospital.
Papers
More filters
Journal ArticleDOI
Sudden arrhythmic death syndrome: familial evaluation identifies inheritable heart disease in the majority of families.
Elijah R. Behr,Chrysoula Dalageorgou,Michael Christiansen,Petros Syrris,S. Hughes,Maria Teresa Tome Esteban,Edward Rowland,Steve Jeffery,William J. McKenna +8 more
TL;DR: Over half of SADS deaths were likely to be due to inherited heart disease; accurate identification is vital for appropriate prophylaxis amongst relatives who should undergo comprehensive cardiological evaluation, guided and confirmed by mutation analysis.
Journal ArticleDOI
Prevalence of exercise-induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy
JS Shah,Maria Teresa Tome Esteban,Rajesh Thaman,Rajan Sharma,Bryan Mist,Antonis Pantazis,Deirdre Ward,Sanjay K Kohli,Steve P. Page,Camelia Demetrescu,Elias Sevdalis,Andre Keren,Denis Pellerin,William J. McKenna,Perry M. Elliott +14 more
TL;DR: It is suggested that all patients with symptomatic non-obstructive HCM should have exercise stress echocardiography to improve functional class and less syncope/presyncope.
Journal ArticleDOI
Prevalence of sarcomere protein gene mutations in preadolescent children with hypertrophic cardiomyopathy.
Juan Pablo Kaski,Petros Syrris,Maria Teresa Tome Esteban,Sharon Jenkins,Antonios Pantazis,John E. Deanfield,William J. McKenna,Perry M. Elliott +7 more
TL;DR: Familial disease is common among infants and children with HCM and that, in most cases, disease is caused by mutations in cardiac sarcomere protein genes, the major implication is that all first-degree relatives of any child diagnosed with H CM should be offered screening.
Journal ArticleDOI
Outcomes after implantable cardioverter-defibrillator treatment in children with hypertrophic cardiomyopathy
Juan Pablo Kaski,Maria Teresa Tome Esteban,Martin Lowe,Simon Sporton,Philip G. Rees,John E. Deanfield,William J. McKenna,Perry M. Elliott +7 more
TL;DR: The experience with ICDs in children with HCM in a single referral centre is reported, showing that life-threatening arrhythmias in high-risk adults with hypertrophic cardiomyopathy (HCM) are successfully treated using implantable cardioverter-defibrillators.
Journal ArticleDOI
Progressive left ventricular remodeling in patients with hypertrophic cardiomyopathy and severe left ventricular hypertrophy.
Rajesh Thaman,Juan R. Gimeno,Juan R. Gimeno,Sebastian Reith,Sebastian Reith,Maria Teresa Tome Esteban,Maria Teresa Tome Esteban,Giuseppe Limongelli,Giuseppe Limongelli,Ross T. Murphy,Ross T. Murphy,Bryan Mist,Bryan Mist,William J. McKenna,William J. McKenna,Perry M. Elliott +15 more
TL;DR: Left ventricular remodeling is common in patients with severe LVH and contributes to the low prevalence of severeLVH seen in middle age and beyond.